Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sipai Health Technology CoHKSE:00314 +2.40%64 PB Ratio is 1.08 as of Aug. 20, 2026, which is 59% below its 10-year median of 2.61. GuruFocus rates HKSE:00314 with a GF Score™ of 64/100 and a GF Value™ of HK$2.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 112 Medical Distribution companies, Sipai Health Technology Co ranks better than 50% on this metric.
The historical rank and industry rank for Sipai Health Technology Co's PB Ratio or its related term are showing as below:
HKSE:00314'
s PB Ratio Range Over the Past 10 Years
Min: 0.87 Med: 2.61 Max: 15.12
Current: 1.08
During the past 7 years, Sipai Health Technology Co's highest PB Ratio was 15.12. The lowest was 0.87. And the median was 2.61.
HKSE:00314's PB Ratio is ranked better than 50% of 112
companies
in the Medical Distribution industry
Industry Median: 1.055
vs HKSE:00314: 1.08
During the past 12 months, Sipai Health Technology Co's average Book Value Per Share Growth Rate was -19.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -19.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Sipai Health Technology Co was -19.90% per year. The lowest was -19.90% per year. And the median was -19.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sipai Health Technology Co PB Ratio Related Terms
Sipai Health Technology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sipai Health Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sipai Health Technology Co (HKSE:00314) has a PB Ratio of 1.08 as of Aug. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sipai Health Technology Co and its competitors. This is 59% below median its historical median of 2.61. Over the past decade, Sipai Health Technology Co's PB Ratio has ranged from 0.87 to 15.12. According to the industry distribution chart, Sipai Health Technology Co ranks #56 out of 112 companies in the Medical Distribution industry, placing it in the top 50%.
Is Sipai Health Technology Co's PB Ratio too high?
Sipai Health Technology Co's current PB Ratio of 1.08 is 59% below median its 10-year median of 2.61. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 15.12. The Medical Distribution industry median PB Ratio is 1.06. Sipai Health Technology Co's value of 1.08 is 2.4% above this industry median. Based on the distribution chart, Sipai Health Technology Co ranks #56 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sipai Health Technology Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #56 out of 112 companies for PB Ratio. This puts Sipai Health Technology Co in the upper half of its industry. The industry median PB Ratio is 1.06. Sipai Health Technology Co's value of 1.08 is 2.4% above this benchmark. Historically, Sipai Health Technology Co's own PB Ratio has ranged from 0.87 to 15.12 over the past decade. While the company's 10-year median is 2.61 vs. the industry median of 1.06, Sipai Health Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.06, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sipai Health Technology Co's current PB Ratio of 1.08 is 2.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current PB Ratio is 1.08, which is 59% below median its own 10-year median of 2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Sipai Health Technology Co (HKSE:00314) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.39, compared to a current price of HK$1.50 — trading 37.4% below its estimated fair value. The current PB Ratio is 1.08, which is 59% below median its 10-year median of 2.61 and 2.4% above the Medical Distribution industry median of 1.06. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sipai Health Technology Co (HKSE:00314), the current PB Ratio is 1.08 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (HKSE:00314) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of HK$1.50 is trading 37.4% below its estimated GF Value™ of HK$2.39.
GuruFocus considers Sipai Health Technology Co to be Possible Value Trap.
Key valuation signals for HKSE:00314:
PB Ratio: 1.08 (59% below median its 10-year median of 2.61)
GF Value™: HK$2.39 vs. price of HK$1.50 (37.4% below fair value)
Industry Position: 2.4% above the Medical Distribution median (#56 of 112)
No single metric tells the full story. See the HKSE:00314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for HKSE:00314
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00314 has been successfully added to your 
